773 related articles for article (PubMed ID: 28685761)
1. Remyelination therapies: a new direction and challenge in multiple sclerosis.
Plemel JR; Liu WQ; Yong VW
Nat Rev Drug Discov; 2017 Sep; 16(9):617-634. PubMed ID: 28685761
[TBL] [Abstract][Full Text] [Related]
2. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
Motavaf M; Sadeghizadeh M; Javan M
Cell Mol Neurobiol; 2017 Nov; 37(8):1335-1348. PubMed ID: 28224237
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances on Immunosuppressive Drugs and Remyelination Enhancers for the Treatment of Multiple Sclerosis.
Cadenas-Fernández J; Ahumada-Pascual P; Andreu LS; Velasco A
Curr Pharm Des; 2021 Oct; 27(30):3273-3280. PubMed ID: 33504299
[TBL] [Abstract][Full Text] [Related]
4. The development of myelin repair agents for treatment of multiple sclerosis: progress and challenges.
Murphy RP; Murphy KJ; Pickering M
Bioengineered; 2013; 4(3):140-6. PubMed ID: 23147071
[TBL] [Abstract][Full Text] [Related]
5. Experimental strategies to promote central nervous system remyelination in multiple sclerosis: insights gained from the Theiler's virus model system.
Miller DJ; Asakura K; Rodriguez M
J Neurosci Res; 1995 Jun; 41(3):291-6. PubMed ID: 7563222
[TBL] [Abstract][Full Text] [Related]
6. Remyelination in multiple sclerosis: realizing a long-standing challenge.
Aharoni R
Expert Rev Neurother; 2015; 15(12):1369-72. PubMed ID: 26558886
[TBL] [Abstract][Full Text] [Related]
7. Remyelination therapy for multiple sclerosis.
Keough MB; Yong VW
Neurotherapeutics; 2013 Jan; 10(1):44-54. PubMed ID: 23070731
[TBL] [Abstract][Full Text] [Related]
8. Repair strategies for multiple sclerosis: challenges, achievements and perspectives.
Stankoff B; Jadasz JJ; Hartung HP; Küry P; Zalc B; Lubetzki C
Curr Opin Neurol; 2016 Jun; 29(3):286-92. PubMed ID: 27035897
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis - remyelination failure as a cause of disease progression.
Hagemeier K; Brück W; Kuhlmann T
Histol Histopathol; 2012 Mar; 27(3):277-87. PubMed ID: 22237705
[TBL] [Abstract][Full Text] [Related]
10. Enhancing central nervous system remyelination in multiple sclerosis.
Dubois-Dalcq M; Ffrench-Constant C; Franklin RJ
Neuron; 2005 Oct; 48(1):9-12. PubMed ID: 16202704
[TBL] [Abstract][Full Text] [Related]
11. Remyelination in multiple sclerosis: a new role for neurotrophins?
Althaus HH
Prog Brain Res; 2004; 146():415-32. PubMed ID: 14699977
[TBL] [Abstract][Full Text] [Related]
12. Promoting remyelination in multiple sclerosis: current drugs and future prospects.
Kremer D; Küry P; Dutta R
Mult Scler; 2015 Apr; 21(5):541-9. PubMed ID: 25623245
[TBL] [Abstract][Full Text] [Related]
13. [The remyelination phenomenon in multiple sclerosis].
Lubetzki C
Bull Acad Natl Med; 2003; 187(4):699-707; discussion 707-10. PubMed ID: 14556477
[TBL] [Abstract][Full Text] [Related]
14. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
Olsen JA; Akirav EM
J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
[TBL] [Abstract][Full Text] [Related]
15. Development of a central nervous system axonal myelination assay for high throughput screening.
Lariosa-Willingham KD; Rosler ES; Tung JS; Dugas JC; Collins TL; Leonoudakis D
BMC Neurosci; 2016 Apr; 17():16. PubMed ID: 27103572
[TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated remyelination: relevance to multiple sclerosis.
Bieber A; Asakura K; Warrington A; Kaveri SV; Rodriguez M
Mult Scler; 2000 Oct; 6 Suppl 2():S1-5; discussion S33. PubMed ID: 11188771
[TBL] [Abstract][Full Text] [Related]
17. Cells of the oligodendroglial lineage, myelination, and remyelination.
Miron VE; Kuhlmann T; Antel JP
Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
[TBL] [Abstract][Full Text] [Related]
18. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
[TBL] [Abstract][Full Text] [Related]
19. Promotion of remyelination by immunoglobulins: implications for the treatment of multiple sclerosis.
Trebst C; Stangel M
Curr Pharm Des; 2006; 12(2):241-9. PubMed ID: 16454740
[TBL] [Abstract][Full Text] [Related]
20. Inflammation stimulates remyelination in areas of chronic demyelination.
Foote AK; Blakemore WF
Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
